Form 4: Director Mark Morelli Acquires Xylem Shares
Statement of Changes in Beneficial Ownership
Director Mark D. Morelli acquired 1,711 restricted stock units of Xylem Inc. as part of an equity incentive plan.
Summary
- Director Mark D. Morelli was granted 1,711 restricted stock units (RSUs) of Xylem Inc. (XYL) common stock.
- The transaction occurred on May 14, 2026, at a price of $116.88 per share.
- Following this transaction, the reporting person holds a total of 8,026 shares of common stock.
- The RSUs are scheduled to vest on the trading day prior to the 2027 Annual Meeting of Shareholders, with settlement deferred until separation from service.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation, which is neutral in terms of immediate market impact.
Positives
- Director demonstrates alignment with shareholder interests through the acquisition of equity.
- The grant is part of a standard long-term incentive plan, indicating continued commitment to the company.
Negatives
- None identified.
Risks
- Market price volatility of Xylem Inc. common stock could impact the future value of the granted RSUs.
Future Outlook
The RSUs are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders.
Industry Context
StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to align leadership incentives with long-term shareholder value in the industrial technology and water infrastructure sectors.
Comparison to Industry Standards
- The use of restricted stock units (RSUs) as a component of director compensation is consistent with standard practices among S&P 500 industrial companies.
- The deferral of settlement until separation from service is a common governance feature to ensure long-term alignment.
Stakeholder Impact
- Positive signal to shareholders regarding director confidence in the company's long-term trajectory.
Next Steps
- Vesting of RSUs on the trading day prior to the 2027 Annual Meeting of Shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/14/2026 | Date of the RSU grant transaction. |
| 05/15/2026 | Date of filing the Form 4. |
Keywords
Xylem, XYL, Director, Insider Trading, Form 4, Equity Incentive
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.